ストックスクリーナーアプリを入手
3.10
2.31%
0.07
アフターアワーズ：
3.21
0.11
+3.55%
前日終値:
$3.03
開ける：
$3.03
24時間の取引高:
307.35K
Relative Volume:
0.46
時価総額：
$389.75M
収益：
$433.14M
当期純損益:
$4.95M
株価収益率:
86.83
EPS:
0.0357
ネットキャッシュフロー:
$6.55M
1週間 パフォーマンス:
-2.82%
1か月 パフォーマンス:
-21.91%
6か月 パフォーマンス:
+11.11%
1年 パフォーマンス:
-16.44%
1日の値動き範囲:
$2.97
$3.13
1週間の範囲:
$2.97
$3.28
52週間の値動き範囲:
$2.165
$4.705
Organogenesis Holdings Inc Stock (ORGO) Company Profile
ORGO を他の銘柄と比較する
| 株式 | 価格 | 時価総額 | 収益 | 当期純利益 | 現金流量 | EPS |
|---|---|---|---|---|---|---|
ORGO
Organogenesis Holdings Inc
|
3.10 | 389.75M | 433.14M | 4.95M | 6.55M | 0.0357 |
|
ZTS
Zoetis Inc
|
163.31 | 73.68B | 9.15B | 2.43B | 2.31B | 5.32 |
|
HLN
Haleon Plc Adr
|
9.46 | 42.77B | 14.26B | 1.55B | 0 | 0.3383 |
|
TAK
Takeda Pharmaceutical Co Adr
|
13.26 | 42.04B | 30.27B | 1.93B | 3.45B | 0.6044 |
|
TEVA
Teva Pharmaceutical Industries Ltd Adr
|
21.24 | 24.07B | 16.77B | -959.00M | 1.37B | -0.85 |
|
VTRS
Viatris Inc
|
12.28 | 14.66B | 15.05B | -883.30M | 1.89B | -0.74 |
Organogenesis Holdings Inc Stock (ORGO) Upgrades & Downgrades
| 日付 | アクション | アナリスト | 評価の変更 |
|---|---|---|---|
| 2024-06-28 | 開始されました | Lake Street | Buy |
| 2024-02-07 | 開始されました | Cantor Fitzgerald | Overweight |
| 2023-06-15 | 開始されました | Morgan Stanley | Equal-Weight |
| 2023-05-24 | アップグレード | BTIG Research | Neutral → Buy |
| 2022-11-10 | ダウングレード | BTIG Research | Buy → Neutral |
| 2022-08-10 | ダウングレード | Oppenheimer | Outperform → Perform |
| 2020-01-10 | 開始されました | SVB Leerink | Outperform |
| 2019-08-26 | 再開されました | Credit Suisse | Outperform |
| 2019-05-02 | 開始されました | Credit Suisse | Outperform |
| 2019-04-17 | 開始されました | Oppenheimer | Outperform |
| 2019-04-11 | 開始されました | SunTrust | Buy |
すべてを表示
Organogenesis Holdings Inc (ORGO) 最新ニュース
Organogenesis Holdings Inc. (NASDAQ:ORGO) Shares Bought by State Street Corp - Defense World
Organogenesis Holdings Inc. (NASDAQ:ORGO) Short Interest Up 29.1% in December - MarketBeat
Organogenesis signs Smithfield lease with subsidies in hand - The Business Journals
Fmr LLC Buys 44,199 Shares of Organogenesis Holdings Inc. (NASDAQ:ORGO) - Defense World
Gary S. Gillheeney Sells 5,585 Shares of Organogenesis Holdings Inc. (NASDAQ:ORGO) Stock - MarketBeat
Organogenesis Holdings Inc. (NASDAQ:ORGO) CEO Gary S. Gillheeney Sells 55,615 Shares - MarketBeat
Organogenesis CEO Gary Gillheeney sells shares worth $206,358 - Investing.com
US Penny Stocks To Consider In December 2024 - Simply Wall St
Charles Schwab Investment Management Inc. Grows Stock Position in Organogenesis Holdings Inc. (NASDAQ:ORGO) - Defense World
Organogenesis Holdings Inc. (NASDAQ:ORGO) Shares Bought by Verition Fund Management LLC - Defense World
Organogenesis Holdings Inc. (NASDAQ:ORGO) Position Cut by BNP Paribas Financial Markets - Defense World
Organogenesis CEO Gary Gillheeney sells shares worth $940,066 - Investing.com
Organogenesis CEO Gary Gillheeney sells shares worth $940,066 By Investing.com - Investing.com UK
Wound Care Market 2024By Industry Outlook, Future Trends, - openPR
Organogenesis CEO Gillheeney sells shares worth $211,721 - Investing.com India
Organogenesis CEO Gillheeney sells shares worth $211,721 By Investing.com - Investing.com Nigeria
Jacobs Levy Equity Management Inc. Lowers Stock Position in Organogenesis Holdings Inc. (NASDAQ:ORGO) - MarketBeat
Organogenesis Holdings Inc (NASDAQ: ORGO) -0.26% Decline Turns Investors Away - Stocks Register
Organogenesis Holdings Inc. announces an Equity Buyback for 500,000 shares, for $2.03 million. - Marketscreener.com
Organogenesis announces stock repurchase at trailing average price By Investing.com - Investing.com Australia
Organogenesis announces stock repurchase at trailing average price - Investing.com
Advantage Alpha Capital Partners LP Trims Holdings in Organogenesis Holdings Inc. (NASDAQ:ORGO) - MarketBeat
News | Massachusetts-based regenerative tissue medical firm expands in Rhode Island - CoStar Group
News | Massachusetts-based regenerative medical firm expands in Rhode Island - CoStar Group
Organogenesis Expands Manufacturing Capacity to Support Future Growth - The Manila Times
Organogenesis Holdings Inc. Expands Manufacturing Capacity to Support Future Growth - Marketscreener.com
Organogenesis Secures 122,000 Sq Ft Biomanufacturing Facility in Major Expansion | ORGO Stock News - StockTitan
Organogenesis Holdings Inc. Appoints Garrett Lustig to the Board - Marketscreener.com
Analysts Set Expectations for Organogenesis FY2024 Earnings - Defense World
Organogenesis Holdings’ $130 Million Private Placement Offering of Series A Convertible Preferred Stock - Global Legal Chronicle
FY2024 EPS Estimates for Organogenesis Boosted by Analyst - MarketBeat
Organogenesis (NASDAQ:ORGO) Releases Quarterly Earnings Results, Beats Expectations By $0.11 EPS - MarketBeat
Organogenesis Commends Final LCDs - The Manila Times
Organogenesis Secures Medicare Coverage for Wound Care Products in Key CMS Decision | ORGO Stock News - StockTitan
Organogenesis (NASDAQ:ORGO) Shares Gap DownWhat's Next? - MarketBeat
Earnings call: Organogenesis tops Q3 revenue forecast with $115.2M - Investing.com
Organogenesis Holdings Secures $130M Investment for Growth - TipRanks
Organogenesis Holdings Inc. (NASDAQ:ORGO) Q3 2024 Earnings Call Transcript - Insider Monkey
Organogenesis secures $130 million investment By Investing.com - Investing.com Australia
Organogenesis Holdings Inc. Reports Third Quarter 2024 Financial Results - The Manila Times
Organogenesis: Q3 Earnings Snapshot - The Washington Post
Organogenesis Reports Robust Third Quarter Growth - TipRanks
Organogenesis (ORGO) Q3 2024 Earnings Call Transcript - The Motley Fool
Organogenesis (ORGO) Tops Q3 Earnings and Revenue Estimates - Yahoo Canada Finance
Organogenesis Holdings Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2024 - Marketscreener.com
Organogenesis Holdings Inc. Announces $130 Million Private Placement Offering of Series A Convertible Preferred Stock - The Manila Times
Organogenesis Secures $130M Investment from Avista, Strengthens Growth Strategy | ORGO Stock News - StockTitan
Organogenesis Holdings Inc (ORGO) 財務データ
収益
当期純利益
現金流量
EPS
Organogenesis Holdings Inc (ORGO) インサイダートレーディング
| インサイダートレーディング | 関係 | 日付 | 取引 | コスト | #株式 | 値 ($) | #株式総数 |
|---|---|---|---|---|---|---|---|
| Gillheeney Gary S. | President and CEO |
Dec 16 '24 |
Sale |
3.49 |
5,585 |
19,492 |
3,039,194 |
| Gillheeney Gary S. | President and CEO |
Dec 11 '24 |
Sale |
3.64 |
157,448 |
573,111 |
3,143,753 |
| Gillheeney Gary S. | President and CEO |
Dec 10 '24 |
Sale |
3.64 |
58,525 |
213,031 |
3,301,201 |
| Gillheeney Gary S. | President and CEO |
Dec 12 '24 |
Sale |
3.55 |
43,359 |
153,924 |
3,100,394 |
| Gillheeney Gary S. | President and CEO |
Dec 05 '24 |
Option Exercise |
0.99 |
1,067,245 |
1,056,573 |
3,419,194 |
| Gillheeney Gary S. | President and CEO |
Dec 09 '24 |
Sale |
3.52 |
41,052 |
144,503 |
3,359,726 |
| Gillheeney Gary S. | President and CEO |
Dec 06 '24 |
Sale |
3.65 |
18,416 |
67,218 |
3,400,778 |
0.58%
2.71%
大文字化:
|
ボリューム (24 時間):